doi:10.16150/j.1671-2870.2018.03.025

[1] Petruzelkova L, Ananieva-Jordanova R, Vcelakova J, et al.The dynamic changes of zinc transporter 8 autoantibodies in Czech children from the onset of Type 1 diabetes mellitus[J]. Diabet Med,2014,31(2):165-171.
[2] Fabris M, Zago S, Liguori M, et al.Anti-zinc transporter protein 8 autoantibodies significantly improve the diagnostic approach to type 1 diabetes: an Italian multicentre study on paediatric patients[J]. Auto Immun Highlights,2015,6(1-2):17-22.
[3] Dunseath G, Ananieva-Jordanova R, Coles R, et al.Bridging-type enzyme-linked immunoassay for zinc transporter 8 autoantibody measurements in adult patients with diabetes mellitus[J]. Clin Chim Acta,2015,447:90-95.
[4] Huang G, Xiang Y, Pan L, et al.Zinc transporter 8 autoantibody (ZnT8A) could help differentiate latent autoimmune diabetes in adults (LADA) from phenotypic type 2 diabetes mellitus[J]. Diabetes Metab Res Rev,2013,29(5):363-368.
[5] 黄干, 孙贵中, 杨琳, 等. 锌转运体8自身抗体和蛋白酪氨酸磷酸酶自身抗体对成人隐匿性自身免疫糖尿病患者胰岛功能的影响[J]. 中华医学杂志,2015,95(20):1563-1567.
[6] Andersen MK, Härkönen T, Forsblom C, et al.Zinc transporter type 8 autoantibodies (ZnT8A): prevalence and phenotypic associations in latent autoimmune diabetes patients and patients with adult onset type 1 diabetes[J].Autoimmunity,2013,46(4):251-258.
[7] Bhadada SK, Rastogi A, Agarwal A, et al.Comparative study of clinical features of patients with celiac disease & those with concurrent celiac disease & type 1 diabetes mellitus[J]. Indian J Med Res,2017,145(3):334-338.
[8] Parkkola A, Härkönen T, Ryhänen SJ, et al.Transglutaminase antibodies and celiac disease in children with type 1 diabetes and in their family members[J]. Pediatr Diabetes,2018,19(2):305-313.
[9] 邹婧, 马漠, 辛可嘉, 等. 组织型转谷氨酰胺酶抗体对1型糖尿病患者乳糜泻的诊断价值及相关临床特点分析[J]. 中华糖尿病杂志,2017,9(10):622-626.
[10] 刘辰庚, 夏鸣, 孟双, 等. 碳酸酐酶Ⅲ自身抗体在1型糖尿病人中的测定[J]. 临床和实验医学杂志,2014,13(1):24-26.
[11] Taniguchi T, Okazaki K, Okamoto M, et al.High prevalence of autoantibodies against carbonic anhydrase Ⅱ and lactoferrin in type 1 diabetes: concept of autoimmune exocrinopathy and endocrinopathy of the pancreas[J]. Pancreas,2003,27(1):26-30.
[12] Taniguchi T, Okazaki K, Okamoto M, et al.Presence of autoantibodies to carbonic anhidrase Ⅱ and lactoferrin in type 1 diabetes: proposal of the concept of autoimmune exocrinopathy and endocrinopathy of the pancreas[J]. Dia-betes Care,2001,24(9):1695-1696.
[13] Türk A, Mollamehmetoğlu S, Alver A, et al.The Relationship between Serum Carbonic Anhydrase I-II Autoantibody Levels and Diabetic Retinopathy in Type 1 Diabetes Patients[J]. Turk J Ophthalmol,2017,47(2):85-88.
[14] Adamus G, Karren L.Autoimmunity against carbonic anhydrase Ⅱ affects retinal cell functions in autoimmune retinopathy[J]. J Autoimmun,2009,32(2):133-139.
[15] Zimering MB, Zhang JH, Guarino PD, et al.Endothelial cell autoantibodies in predicting declining renal function, end-stage renal disease, or death in adult type 2 diabetic nephropathy[J]. Front Endocrinol (Lausanne),2014,5:128.
[16] 赵秀玲. 糖尿病肾病患者抗内皮细胞抗体表达与炎性细胞因子水平关系分析[J]. 临床医学研究与实践,2017,2(18):17-18.
[17] Goetze JP, Alehagen U, Flyvbjerg A, et al.Chromogranin A as a biomarker in cardiovascular disease[J]. Biomark Med,2014,8(1):133-140.
[18] Portela-Gomes GM, Gayen JR, Grimelius L, et al.The importance of chromogranin A in the development and function of endocrine pancreas[J]. Regul Pept,2008,151(1-3):19-25.
[19] 李艳玲, 陈晔, 彭丽, 等. 1型糖尿病免疫学研究进展[J]. 国际内分泌代谢杂志,2013,33(4):247-249.
[20] Nikoopour E, Sandrock C, Huszarik K, et al.Cutting edge: vasostatin-1-derived peptide ChgA29-42 is an antigenic epitope of diabetogenic BDC2.5 T cells in nonobese diabetic mice[J]. J Immunol,2011,186(7):3831-3835.
[21] Gottlieb PA, Delong T, Baker RL, et al.Chromogranin A is a T cell antigen in human type 1 diabetes[J]. J Autoimmun,2014,50:38-41.
[22] Nikoopour E, Cheung R, Bellemore S, et al.Vasostatin-1 antigenic epitope mapping for induction of cellular and humoral immune responses to chromogranin A autoantigen in NOD mice[J]. Eur J Immunol,2014,44(4):1170-1180.
[23] Westermark P, Andersson A, Westermark GT.Islet amyloid polypeptide, islet amyloid, and diabetes mellitus[J]. Physiol Rev,2011,91(3):795-826.
[24] Tomita T.Islet amyloid polypeptide in pancreatic islets from type 1 diabetic subjects[J]. Islets,2011,3(4):166-174.
[25] Baker RL, Delong T, Barbour G, et al.Cutting edge: CD4 T cells reactive to an islet amyloid polypeptide peptide accumulate in the pancreas and contribute to disease pathogenesis in nonobese diabetic mice[J]. J Immunol,2013,191(8):3990-3994.
[26] Delong T, Baker RL, Reisdorph N, et al.Islet amyloid polypeptide is a target antigen for diabetogenic CD4+ T cells[J]. Diabetes,2011,60(9):2325-2330.
[27] Gorus FK, Sodoyez JC, Pipeleers DG, et al.Detection of autoantibodies against islet amyloid polypeptide in human serum. Lack of association with type 1 (insulin-dependent) diabetes mellitus, or with conditions favouring amyloid deposition in islets. The Belgian Diabetes Regi-stry[J]. Diabetologia,1992,35(11):1080-1086.
[28] Paulsson JF, Ludvigsson J, Carlsson A, et al.High plasma levels of islet amyloid polypeptide in young with newo-nset of type 1 diabetes mellitus[J]. PLoS One,2014,9(3):e93053.
[29] Khoo C, Yang J, Weinrott SA, et al.Research resource: the pdx1 cistrome of pancreatic islets[J]. Mol Endocrinol,2012,26(3):521-533.
[30] Wang RH, Xu X, Kim HS, et al.SIRT1 deacetylates FOXA2 and is critical for Pdx1 transcription and β-cell formation[J]. Int J Biol Sci,2013,9(9):934-946.
[31] Yuan Y, Hartland K, Boskovic Z, et al.A small-molecule inducer of PDX1 expression identified by high-throughput screening[J]. Chem Biol,2013,20(12):1513-1522.
[32] Chun SY, Mack DL, Moorefield E, et al.Pdx1 and controlled culture conditions induced differentiation of human amniotic fluid-derived stem cells to insulin-produ-cing clusters[J]. J Tissue Eng Regen Med,2015,9(5):540-549.
[33] Yu H, Sun Z, Cui J, et al.Epidermal growth factor and gastrin on PDX1 expression in experimental type 1 diabetic rats[J]. Am J Med Sci,2012,343(2):141-145.
[34] Shternhall-Ron K, Quintana FJ, Perl S, et al.Ectopic PDX-1 expression in liver ameliorates type 1 diabetes[J]. J Autoimmun,2007,28(2-3):134-142.
[35] Donelan W, Wang H, Li SW, et al.Novel detection of pancreatic and duodenal homeobox 1 autoantibodies (PAA) in human sera using luciferase immunoprecipitation systems (LIPS) assay[J]. Int J Clin Exp Pathol,2013, 6(6):1202-1210.

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Chinese Society of Endocrinology,Chinese Medical Association , et al . Expert suggestion for diabetes management during the recent COVID-19 pandemic [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 136-138.
[2]	CHEN Xuyang, GU Weiqiong. Study on detection of insulin autoimmune antibodies: limitation and countermeasures [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(01): 95-98.
[3]	WANG Guangyu, YANG Xin, ZHANG Lijuan, TAN Jiaorong. The relationship between plasma total testosterone and osteocalcin levels in males with newly diagnosed type 2 diabetes [J]. Journal of Diagnostics Concepts & Practice, 2021, 20(06): 573-578.
[4]	. [J]. Journal of Diagnostics Concepts & Practice, 2021, 20(02): 130-137.
[5]	. [J]. Journal of Diagnostics Concepts & Practice, 2020, 19(03): 225-228.
[6]	WANG Shanshan, ZHOU Yingxia, HU Lijuan, NIU Jingya, WANG Tiange, LI Mian, ZHAO Zhiyun, XU Yu, LU Jieli, XU Min, BI Yufang, NI Hengru. The correlation between different fat distribution indices and dyslipidemia in middle-aged population in Shanghai [J]. Journal of Diagnostics Concepts & Practice, 2019, 18(2): 177-182.
[7]	DENG Lin, DING Yi, WANG Ping, BIAN Bingxian, SHEN Lisong. Application of urinary neutrophil gelatinase-associated lipocalin/creatinine ratio in early diagnosis and severity assessment of renal injury in patients with type 2 diabetes mellitus [J]. Journal of Diagnostics Concepts & Practice, 2019, 18(1): 61-65.
[8]	HOU Yanan, XUAN Liping, ZHAO Zhiyun, LI Mian, CHEN Yuhong, DAI Meng, XU Min, BI Yufang, WANG Weiqing, GAO Jinli. Epidemiological study on association of uric acid to creatinine ratio with metabolic syndrome in middle-aged and elderly populationin Shanghai [J]. Journal of Diagnostics Concepts & Practice, 2019, 18(1): 44-50.
[9]	XUAN Liping, HOU Yanan, PENG Kui, ZHAO Zhiyun, LI Mian, CHEN Yuhong, DAI Meng, XU Min, BI Yufang, WANG Weiqing, ZHANG Di, XU Jiji. Correlation of subclinical hypothyroidism with carotid intima media thickness in Chinese population [J]. Journal of Diagnostics Concepts & Practice, 2018, 17(04): 444-448.
[10]	JI Pengcheng, ZHANG Shu, SUN Jing, JIANG Shihu. Analysis on levels of vitamins in middle-aged and elderly patients with diabetes mellitus in Shanghai [J]. Journal of Diagnostics Concepts & Practice, 2018, 17(03): 285-289.
[11]	. [J]. Journal of Diagnostics Concepts & Practice, 2018, 17(03): 357-359.
[12]	DU Yiqiao, WANG Wenhui, LIU Wanchao, NIU Jing, SHI Xuejuan, YANG Zhenhua. Establishment of a normal reference range for 1,5-anhydroglucitol [J]. Journal of Diagnostics Concepts & Practice, 2018, 17(02): 181-185.
[13]	. [J]. Journal of Diagnostics Concepts & Practice, 2018, 17(01): 5-10.
[14]	LIN Ruhai, WU Xiaohong, JIANG Zhengrong, YANG Xinna, ZHUANG Duanrong, WU Lizhen.. Associated factors for within-day and day-to-day glycemic variability in type 2 diabetes patients [J]. Journal of Diagnostics Concepts & Practice, 2017, 16(05): 516-521.
[15]	JI Pengcheng, ZHANG Shu, SUN Jing, JIANG Shihu. Analysis on changes in minerals in middle-aged and elderly patients with diabetes mellitus in Shanghai [J]. Journal of Diagnostics Concepts & Practice, 2017, 16(05): 522-526.